|
|
 |
 |
|
|
|
|
 |
|
|
|
|
|
|
|
表 題 |
著者名 |
誌
名 |
Oncology |
| Overall survival and final efficacy and safety results from a Japanese phase II study of axitinib in cytokine-refractory metastatic renal cell carcinoma. |
Eto M, Uemura H, Tomita Y, Kanayama H, Shinohara N, Kamei Y, Fujii Y, Umeyama Y, Ozono S, Naito S, Akaza H; Japan Axitinib Phase II Study Group: |
Cancer Sci 105 (12): 1576-1583, 2014 |
| Acute urinary morbidity after a permanent 125I implantation for localized prostate cancer. |
Ohga S, Nakamura K, Shioyama Y, Tatsugami K, Sasaki T, Nonoshita T, Yoshitake T, Asai K, Hirata H, Naito S, Honda : |
J Radiat Res 55 (6): 1178-1183, 2014 |
| Risk factors for febrile neutropenia in patients receiving docetaxel chemotherapy for castration-resistant prostate cancer. |
Shiota M, Yokomizo A, Takeuchi A, Kiyoshima K, Inokuchi J, Tatsugami K, Naito S: |
Support Care Cancer 22 (12): 3219-3226, 2014 |
| The Oncological Outcomes and Risk Stratification in Docetaxel Chemotherapy for Castration-resistant Prostate Cancer. |
Shiota M, Yokomizo A, Adachi T, Koga H, Yamaguchi A, Imada K, Takeuchi A, Kiyoshima K, Inokuchi J, Tatsugami K, Naito S: |
Jpn J Clin Oncol 44 (9): 860-867, 2014 |
| Recent Trends in the Initial Therapy for Newly Diagnosed Prostate Cancer in Japan. |
Onozawa M, Hinotsu S, Tsukamoto T, Oya M, Ogawa O, Kitamura T, Suzuki K, Naito S, Namiki M, Nishimura K, Hirao Y, Akaza H: |
Jpn J Clin Oncol 44 (10): 969-981, 2014 |
| Time Course of Calcium Concentrations and Risk Factors for Hypocalcemia in Patients Receiving Denosumab for the Treatment of Bone Metastases From Cancer. |
Ikesue H, Tsuji T, Hata K, Watanabe H, Mishima K, Uchida M, Egashira N, Miyamoto T, Baba E, Akashi K, Takayama K, Nakanishi Y, Tokunaga E, Okamoto T, Maehara Y, Yokomizo A, Naito S, Kubo M, Tanaka M, Masuda S: |
Ann Pharmacother 48 (9): 1159-1165, 2014 |
| The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomy. |
Shiota M, Yokomizo A, Takeuchi A, Imada K, Kiyoshima K, Inokuchi J, Tatsugami K, Naito S: |
J Surg Oncol 110 (4): 476-481,2014 |
| PMA induces androgen receptor downregulation and cellular apoptosis in prostate cancer cells. |
Itsumi M, Shiota M, Yokomizo A, Takeuchi A, Kashiwagi E, Dejima T, Inokuchi J, Tatsugami K, Uchiumi T, Naito S: |
J Mol Endocrinol 53 (1): 31-41, 2014 |
| Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer. |
Shiota M, Yokomizo A, Takeuchi A, Itsumi M, Imada K, Kashiwagi E, Inokuchi J, Tatsugami K, Uchiumi T, Naito S: |
Prostate 74 (9): 959-969, 2014 |
| Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer. |
Shiota M, Itsumi M, Yokomizo A, Takeuchi A, Imada K, Kashiwagi E, Inokuchi J, Tatsugami K, Uchiumi T, Naito S: |
Prostate 74 (8): 829-838, 2014 |
| Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: The first large-scale study from the Cancer Registration Committee of the Japanese Urological Association. |
Miki T, Kamoi K, Fujimoto H, Kanayama HO, Ohyama C, Suzuki K, Nishiyama H, Eto M, Naito S, Fukumori T, Kubota Y, Takahashi S, Mikami K, Homma Y: |
Int J Urol 21 (8): S1-6, 2014 |
| Japan Study Group of Prostate Cancer (J-CaP): Age at diagnosis on prostate cancer survival undergoing androgen deprivation therapy as primary treatment in daily practice: results from Japanese observational cohort. |
Inamoto T, Azuma H, Hinotsu S, Tsukamoto T, Oya M, Ogawa O, Kitamura T, Kazuhiro S, Naito S, Namiki M, Nishimura K, Hirao Y, Usami M, Murai M, Akaza H; |
J Cancer Res Clin Oncol 140 (7): 1197-1204, 2014 |
| Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209. |
Kitamura H, Tsukamoto T, Shibata T, Masumori N, Fujimoto H, Hirao Y, Fujimoto K, Kitamura Y, Tomita Y, Tobisu K, Niwakawa M, Naito S, Eto M, Kakehi Y; ?Urologic Oncology Study Group of the Japan Clinical Oncology Group: |
Ann Oncol 25 (6): 1192-1198, 2014 |
| Oncological outcomes of renal pelvic and ureteral cancer patients registered in 2005: The first large population report from the Cancer Registration Committee of the Japanese Urological Association. |
Fujimoto H, Nakanishi H, Miki T, Kanayama HO, Ohyama C, Suzuki K, Nishiyama H, Eto M, Naito S, Fukumori T, Kubota Y, Takahashi S, Homma Y, Kamoi K: |
Int J Urol 21 (5): 527-534, 2014 |
| EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer. |
Kashiwagi E, Shiota M, Yokomizo A, Inokuchi J, Uchiumi T, Naito S: |
Prostate Cancer Prostatic Dis 17 (1): 10-17, 2014 |
| Insulin-like growth factor-I induces CLU expression through Twist1 to promote prostate cancer growth. |
Takeuchi A, Shiota M, Beraldi E, Thaper D, Takahara K, Ibuki N, Pollak M, Cox ME, Naito S, Gleave ME, Zoubeidi A: |
Mol Cell Endocrinol 384 (1-2): 117-125, 2014 |
| Inhibition of protein kinase c/twist1 signaling augments anticancer effects of androgen deprivation and enzalutamide in prostate cancer |
Shiota M, Yokomizo A, Takeuchi A, Imada K, Kashiwagi E, Song Y, Inokuchi J, Tatsugami K, Uchiumi T, Naito S: |
Clin Cancer Res 20 (4): 951-961, 2014 |
| A randomized multicenter phase II trial on the efficacy of a hydrocolloid dressing containing ceramide with a low-friction external surface for hand-foot skin reaction caused by sorafenib in patients with renal cell carcinoma. |
Shinohara N, Nonomura N, Eto M, Kimura G, Minami H, Tokunaga S, Naito S: |
Ann Oncol 25 (2): 472-476, 2014 |
| Final results of a phase II study of S-1 in patients with Cytokine-refractory metastatic renal cell carcinoma. |
Naito S, Tatsugami K, Shinohara N, Tomita Y, Mizokami A, Fujisawa M, Hashine K, Nishikido M, Nakagawa M, Tsukamoto T, Akaza H: |
Jpn J Clin Oncol 44 (2): 122-126, 2014 |
| Twist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer. |
Song YH, Shiota M, Yokomizo A, Uchiumi T, Kiyoshima K, Kuroiwa K, Oda Y, Naito S: |
Urol Oncol 32 (1): 1-7, 2014 |
Infectious Disease |
| Treatment of acute uncomplicated cystitis with faropenem for 3 days versus 7 days: multicentre, randomized, open-label, controlled trial. |
Hamasuna R, Tanaka K, Hayami H, Yasuda M, Takahashi S, Kobayashi K, Kiyota H, Yamamoto S, Arakawa S, Matsumoto T; on behalf of the Japanese Research Group for UTI (JRGU): |
J Antimicrob Chemother 69 (6): 1675-1680, 2014 |
Neurourology |
| Differential contribution of Kv4-containing channels to A-type, voltage-gated potassium currents in somatic and visceral dorsal root ganglion neurons. |
Yunoki T, Takimoto K, Kita K, Funahashi Y, Takahashi R, Matsuyoshi H, Naito S, Yoshimura N: |
J Neurophysiol 112 (10): 2492-2504, 2014 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
